Pautas de detección, prevención y tratamiento de la nefropatía diabética en españa

Autor: F. de Alvaro Moreno, P.L. de Pablos Velasco, E. Esmatjes Mompó, A. Fernández Escribano, E. Lurbe Ferrer, R. Marín Iranzo, J.L. Martín Manzano, A. Martínez Castelao, J.J. Mediavilla Bravo, D. Orozco Beltrán, L. Orte Martínez, R. Romero González, D. Sanz Guajardo

Publikováno v: Hipertensión y Riesgo Vascular. 19:412-420

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dce9b5724fb3544072ab78a5c04c835f
https://doi.org/10.1016/s1889-1837(02)71328-7

Effects of Alloxan-Induced Diabetes on Hemorheology in Rabbits

Autor: E. A. Friedman, S. Berweck, S. Chan, Z. H. Zhao, F. De Alvaro, C. D. Brown

Publikováno v: Hormone and Metabolic Research. 24:254-257

Plasma viscosity (PV), apparent whole blood viscosity (WBV), relative blood viscosity (RV) and erythrocyte deformability (filterability) (EDF) were determined in 13 New Zealand White (NZW) rabbits with alloxan induced-diabetes (AID) and 8 normal NZW

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1095d5546c0de77434a7d9a4ea8548c3
https://doi.org/10.1055/s-2007-1003307

[HDL cholesterol and cardiovascular disease in a population with hypertension and type 2 diabetes mellitus. RICARHD Study]

Autor: P, Conthe, P, Gómez-Fernández, F, de Alvaro, C, Fernández-Pérez, J, González-Esteban, L, Cea-Calvo

Publikováno v: Revista clinica espanola. 209(5)

To assess the prevalence of low serum levels of HDL cholesterol (HDL-C) and its relationship with the presence of cardiovascular disease (CVD) in patients with type 2 diabetes mellitus (DM) and arterial hypertension attended in Internal Medicine and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8ede382a77dd036acd4a0795d6d721e7
https://pubmed.ncbi.nlm.nih.gov/19480779

C.E.R.A. Corrects Anemia in Patients with Chronic Kidney Disease not on Dialysis: Results of a Randomized Clinical Trial

Autor: Francesco Locatelli, Rowan G. Walker, M. Formica, G. Choukroun, N. Kopyt, Paul C. Nader, U. Frei, Alan W. McMahon, A. Martinez Castelao, G. Papadakis, R. Burgos-Calderon, E. Imbasciati, A. Fine, Carmine Zoccali, Steven J. Rosansky, L. Frenken, Norman Muirhead, Paul E. Barre, Csaba P. Kovesdy, Frank C. Dougherty, I. C. Macdougall, G. Pylypchuk, J. Kwan, V. Esnault, George M. Nassar, Ulrich Beyer, Charmaine E. Lok, Robert Provenzano, R. Schmidt, D. Fischer, R. Solomon, D. Durand, I. MacPhee, R. Walker, V. Pichette, B. Stegmayr, Thomas A. Golper, Shivinder S. Jolly, C. Vela, Michèle Kessler, M. del Pino y Pino, M. Suranyi, F. de Alvaro, G. Sakellariou, T. Risler, Maurice Laville, Sean Murphy, J. E Marco Franco, P. Tam, K. Warr, S. Noble, G. Carpenito, P. C. Nader, Marcello Amato, G. Deferrari, H. R. Locay, C. Wijeyesinghe, C. Breen, Giuseppe Villa, Sheldon W. Tobe, Adeera Levin, C. Jacquot, G. P. Dragoun, P. Evenepoel, A. Balducci, R. Lafayette, Paolo Altieri, Fernando de Alvaro, J. Kraut, B. Faller, I. Papadakis, Bruce F. Culleton, D. Rodriguez Puyol, M. Annerstedt, C. Hagen, Kostas C. Siamopoulos, Rainer P. Woitas, F. Locatelli, L. Craver, Iain C. Macdougall, Peter G. Kerr, K. Harris, K. Hahn, Jeffrey G. Penfield, Bruce Spinowitz, Vassilis Vargemezis, E. Morales Ruiz, George A. Kaysen, Harold R. Locay, Edwina A. Brown

Background and objectives: This study examined the efficacy of C.E.R.A., a continuous erythropoietin receptor activator, for correcting anemia in patients who had chronic kidney disease (CKD) and were not on dialysis. Design, setting, participants, &

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9aa0d849595437aa1c34fe0f7e1c49d
https://europepmc.org/articles/PMC2390949/

[Familial Henoch-Schönlein purpura manifested with lung hemorrhage]

Autor: S, Ros, J, Martínez Ara, M A, García de Miguel, T, Olea, F, de Alvaro

Publikováno v: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 24(5)

Henoch-Schönlein purpura (HSP) is a necrotizing vasculitis affecting small vessels characterized by nontrombocytopenic purpura. The most characteristic clinical manifestations are purpura, arthritis, abdominal pain, abdominal bleeding and nephritis.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::54d1ad84d9432d9f1be7b327d943285e
https://pubmed.ncbi.nlm.nih.gov/15648910